Oct

6

2021

If a patient with deep vein thrombosis (DVT) is not treated with DOAC, what is the preferred next choice of anticoagulant?

By William Aird

A

If a patient with deep vein thrombosis (DVT) is not treated with DOAC, what is the preferred next choice of anticoagulant?

Vitamin K antagonist is preferred over low-molecular weight heparin (LMWH).

2016 ACCP guideline

Posted on October 6, 2021

Stay Updated

If you are interested in getting the latest articles from The Blood Project, enter your name and email

  • This field is for validation purposes and should be left unchanged.